Financial results

1Q 2021 consolidated results

Consolidated Income Statement Data
(Thousands of euro)	1Q 2021	1Q 2020
Total net sales	41,038	49,285
Gross profit	15,915	20,358
% on sales	38.8%	41.3%
Operating income	2,238	6,841
% on sales	5.5%	13.9%
EBITDA	5,007	9,384
% on sales	12.2%	19.0%
Net income (loss) from continued operations	1,381	-5,074
% on sales	3.4%	-10.3%
Group net income	1,381	-5,074
% on sales	3.4%	-10.3%

Consolidated Balance Sheet Data
(Thousands of euro)	March 31, 2021	December 31, 2020
Group shareholders' equity	244,900	238,162
Net financial position	92,351	95,742

COMPARISON WITH THE FIRST QUARTER OF 2020 NOT SIGNIFICANT DUE TO THE STILL LIMITED IMPACT OF COVID-19 ON 1Q 2020 REVENUES

STRONG GROWTH IN SALES OF THE MEDICAL AND ADVANCED PACKAGING DIVISIONS COMPARED TO 4Q 2020

Consolidated revenues equal to €41 million, compared to €49.3 million in 1Q 2020
Consolidated revenues organically increased by 1.9% in 1Q 2021 compared to 4Q 2020
Consolidated gross profit equal to €15.9 million compared to €20.4 million in 1Q 2020
Consolidated operating income equal to €2.2 million compared to €6.8 million in 1Q 2020
Consolidated EBITDA equal to €5 million (12.2% of consolidated revenues) compared to €9.4 million in 1Q 2020 (19% of consolidated revenues)
Consolidated net income positive and equal to €1.4 million compared to a negative consolidated net income of -€5.1 million in 1Q 2020, but not significant comparison due to the strong penalizing effect of Covid-19 on the 1Q 2020 financial management
Consolidated net financial position positive and equal to €92.4 million as at March 31, 2021